244 related articles for article (PubMed ID: 25133187)
1. Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.
Morita SY; Terada T
Biomed Res Int; 2014; 2014():954781. PubMed ID: 25133187
[TBL] [Abstract][Full Text] [Related]
2. ABCB4/MDR3 in health and disease - at the crossroads of biochemistry and medicine.
Prescher M; Kroll T; Schmitt L
Biol Chem; 2019 Sep; 400(10):1245-1259. PubMed ID: 30730833
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of Taurohyodeoxycholate-induced Biliary Phospholipid Efflux -Understanding the Function of the ABCB4 Enhancer for Developing Therapeutic Agents against Bile Salt-induced Liver Injury].
Ikeda Y
Yakugaku Zasshi; 2020; 140(11):1329-1334. PubMed ID: 33132268
[TBL] [Abstract][Full Text] [Related]
4. Bile salt-stimulated phospholipid efflux mediated by ABCB4 localized in nonraft membranes.
Morita SY; Tsuda T; Horikami M; Teraoka R; Kitagawa S; Terada T
J Lipid Res; 2013 May; 54(5):1221-30. PubMed ID: 23468132
[TBL] [Abstract][Full Text] [Related]
5. Enhancing effect of taurohyodeoxycholate on ABCB4-mediated phospholipid efflux.
Ikeda Y; Morita SY; Hatano R; Tsuji T; Terada T
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1495-1502. PubMed ID: 31176036
[TBL] [Abstract][Full Text] [Related]
6. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms for Protection of Hepatocytes against Bile Salt Cytotoxicity.
Morita SY; Ikeda Y; Tsuji T; Terada T
Chem Pharm Bull (Tokyo); 2019; 67(4):333-340. PubMed ID: 30930437
[TBL] [Abstract][Full Text] [Related]
8. Bile salt-dependent efflux of cellular phospholipids mediated by ATP binding cassette protein B4.
Morita SY; Kobayashi A; Takanezawa Y; Kioka N; Handa T; Arai H; Matsuo M; Ueda K
Hepatology; 2007 Jul; 46(1):188-99. PubMed ID: 17523162
[TBL] [Abstract][Full Text] [Related]
9. Lipid flopping in the liver.
Linton KJ
Biochem Soc Trans; 2015 Oct; 43(5):1003-10. PubMed ID: 26517915
[TBL] [Abstract][Full Text] [Related]
10. ABCB4 disease: Many faces of one gene deficiency.
Sticova E; Jirsa M
Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
[TBL] [Abstract][Full Text] [Related]
11. Genetic Analysis of
Wang HH; Portincasa P; Liu M; Wang DQ
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741809
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of ABCB4/MDR3 ATPase activity requires an intact phosphatidylcholine lipid.
Prescher M; Smits SHJ; Schmitt L
J Lipid Res; 2020 Dec; 61(12):1605-1616. PubMed ID: 32917728
[TBL] [Abstract][Full Text] [Related]
13. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
[TBL] [Abstract][Full Text] [Related]
14. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).
Oude Elferink RP; Paulusma CC
Pflugers Arch; 2007 Feb; 453(5):601-10. PubMed ID: 16622704
[TBL] [Abstract][Full Text] [Related]
15. Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity.
Groen A; Romero MR; Kunne C; Hoosdally SJ; Dixon PH; Wooding C; Williamson C; Seppen J; Van den Oever K; Mok KS; Paulusma CC; Linton KJ; Oude Elferink RP
Gastroenterology; 2011 Nov; 141(5):1927-37.e1-4. PubMed ID: 21820390
[TBL] [Abstract][Full Text] [Related]
16. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
[TBL] [Abstract][Full Text] [Related]
17. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
[TBL] [Abstract][Full Text] [Related]
18. Liver diseases related to MDR3 (ABCB4) gene deficiency.
Gonzales E; Davit-Spraul A; Baussan C; Buffet C; Maurice M; Jacquemin E
Front Biosci (Landmark Ed); 2009 Jan; 14(11):4242-56. PubMed ID: 19273348
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of biliary lipid secretion and its defects.
Elferink RP; Groen AK
Gastroenterol Clin North Am; 1999 Mar; 28(1):59-74, vi. PubMed ID: 10198778
[TBL] [Abstract][Full Text] [Related]
20. Genetic cholestasis, causes and consequences for hepatobiliary transport.
Jansen PL; Sturm E
Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]